Pasireotide-resistant Refractory Cushing's Disease without Somatostatin Receptor 5 Expression

Pasireotide, which has a high affinity for somatostatin receptor (SSTR) 5, has attracted attention as a new treatment for refractory Cushing's disease. The patient was a 28-year-old man. He had refractory Cushing's disease and underwent multiple surgeries, radiotherapy, and medication ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizuno, Tomoko, Inoshita, Naoko, Fukuhara, Noriaki, Tatsushima, Keita, Takeshita, Akira, Yamada, Shozo, Nishioka, Hiroshi, Takeuchi, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943369/
https://www.ncbi.nlm.nih.gov/pubmed/34471015
http://dx.doi.org/10.2169/internalmedicine.6314-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943369/
https://www.ncbi.nlm.nih.gov/pubmed/34471015
http://dx.doi.org/10.2169/internalmedicine.6314-20

Ejemplares similares